Dr. Anna E***

Tumor Hypoxia and Metabolic Reprogramming Apoptosis Resistance and BCL-2 Family Signaling Oncolytic Viral Therapies Targeted Oncogenic Kinase Inhibitors Metastatic Lymph Node Colonization Mechanisms Precision Pediatric Oncology Genomics Melanoma Resistance to BRAF/MEK Inhibitors Glioblastoma Stem Cells and Radioresistance Patient-Derived Organoids for Drug Screening Proteomics of Cancer Drug Resistance Cancer Metabolism and Glutamine Addiction CAR-T Cell Therapy and Adoptive Cell Transfer Colorectal Cancer Mutational Signatures Phase Separation and Biomolecular Condensates Single-Cell RNA Sequencing Methodologies CRISPR-Cas9 Functional Genomics Stem Cell Pluripotency and Nuclear Reprogramming Non-Coding RNAs and Enhancer RNAs Mass Spectrometry-Based Clinical Proteomics DNA Replication Fork Stability and Stalled Forks Autophagy and Proteasome Protein Degradation